Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diamond Shamrock Corporation was a diversified American industrial conglomerate that maintained a significant presence in the life sciences sector through its dedicated biosciences and animal health divisions. The company was a major producer of agricultural chemicals and veterinary medicines, most notably developing the widely used fungicide chlorothalonil (Daconil). During the 1980s, the company expanded its reach in the life sciences through SDS Biotech, a joint venture with Showa Denko focused on global agrochemical and animal health markets. Following a series of corporate restructurings and divestitures in the late 1980s, its life science assets were sold to various entities, while its refining and chemical businesses were eventually absorbed by Valero Energy and Occidental Petroleum.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diamond Shamrock.